Kwame Appenteng

Astellas Pharma US, Chicago, IL, USA

Presentation(s):

• Lightning Presentations Session 1

  Monday, August 23, 2021
  5:30 PM – 6:30 PM US Eastern Time

• OP-25B - Cardiovascular Risk in Users of Mirabegron Relative to Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-interventional, Real-world Data Safety Study

  Tuesday, August 24, 2021
  1:45 PM – 3:30 PM US Eastern Time